Journal of Modern Nursing MedicineJPCNS

Objective Analysis of the efficacy evaluation of phentolamine combined with tranexamic acid in the treatment of pulmonary tuberculosis with hemoptysis. Methods Sixty cases of pulmonary tuberculosis complicated with hemoptysis treated in our hospital from January 2022 to December 2023 were selected as the research sample. They were then randomly divided into a control group (30 cases, treated with tranexamic acid) and an observation group (30 cases, treated with phentolamine combined with tranexamic acid) to compare the clinical treatment effects of the two groups. Results The observation group had higher arterial oxygen partial pressure and lower carbon dioxide partial pressure (P<0.05), and better lung function indicators FEV1 and FVC (P<0.05). The inflammatory indicators and total hemoptysis in the observation group were lower (P<0.05), and the symptom improvement time was shorter (P<0.05). The statistical results of the incidence of adverse reactions between the observation group and the control group showed no significant statistical difference (P>0.05). Conclusion The combination therapy of phentolamine and tranexamic acid has achieved significant clinical efficacy for patients with pulmonary tuberculosis complicated with hemoptysis. Worth promoting and applying.

Phentolamine; Tranexamic acid; Pulmonary tuberculosis; Hemoptysis